Sometime next week medicalmarijuana.com.au will have the honour of interviewing the esteemed molecular biologist Dr Cristina Sánchez PhD.
Dr Sanchez has devoted the past 10 years to cannabinoid research, and most recently ” new cannabinoid receptors and their possible involvement in cannabinoid antitumoral action in breast cancer and other type of tumors.”
Now with this honour comes great responsibility! What do I ask a such an educated person on the subject of medical cannabis?
Then my friend Dennis Hill came to mind. I put the question to Dennis and he quickly replied with these two pertinent questions: (Thanks Dennis)
We know that CBD inhibits the mental effects of THC, but does this action also inhibit any of the therapeutic capabilities of THC? Do you know the mechanism of how CBD inhibits the mental effects of THC?
Please explain the entourage effect of how phytocannabinoids and other cannabis enzymes work cooperatively to efficiently and effectively treat cancer?
So now I have two great questions for Cristina, but I want more!
Hence, I’m giving you bloggers and supporters of Patients for Medical Cannabis the opportunity to ask Dr Cristina Sánchez a question related to her research. No guarantees the questions will be used, but all questions are much appreciated.
Please email email@example.com before 19/7/15 or 7/19/15 ….. by next Sunday.
About Dr Cristina Sánchez;
Cristina Sánchez (Madrid, Spain, 1971) graduated in Biology at Madrid Complutense University in 1994.
She started her scientific career as an undergraduate student at the laboratory of Dr. Ramos and Dr. Fernández Ruiz (School of Medicine, Complutense University), where she first took contact with the field of cannabinoid research. Once graduated, she moved to Dr. Guzmán’s laboratory (School of Biology, Complutense University), where she studied the effect of cannabinoids on lipid and carbohydrate intermediate metabolism first and on cancer cell proliferation later. She obtained her PhD with Honors in Biochemistry and Molecular Biology at Complutense University in 2000.
During her postdoc at Dr. Piomelli’s laboratory (University of California Irvine, 20002003) she studied the involvement of another group of bioactive lipids (lysophosphatidic acid and related compounds) on pain initiation.
In 2004, Cristina returned to Spain with a “Ramón y Cajal” contract (aimed at repatriating Spanish researchers from abroad) and she started coordinating a new line of research within Dr. Guzmán’s laboratory. In particular, the goal of her research is to understand and exploit cannabinoids as potential antitumoral agents in breast cancer. More recently, she has also focused her attention on new cannabinoid receptors and their possible involvement in cannabinoid antitumoral action in breast cancer and other type of tumors.
recent publications Dr Cristina Sánchez has been involved with can be viewed here: